Chicago, ILNCT05382572Now EnrollingIRB Ready

Pulmonary Fibrosis Clinical Trial in Chicago, IL

Access cutting-edge pulmonary fibrosis treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by Pulmonary Fibrosis Foundation

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access pulmonary fibrosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pulmonary fibrosis treatment provided free

Apply for This Chicago Location

Check if you qualify for this pulmonary fibrosis clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Pulmonary Fibrosis Study in Chicago

Pulmonary fibrosis (PF) results from a diverse group of health conditions and affects the lives of patients (including those who are post lung transplant), caregivers and family members. The Pulmonary Fibrosis Foundation Community Registry will offer an online portal where participants can self-enroll and directly contribute information about their experience with PF to be compiled into a longitudinal data set for use by researchers.

Sponsor: Pulmonary Fibrosis Foundation

Who Can Participate

Inclusion Criteria

In order to be eligible to participate in this study, an individual must meet all of the following criteria:
Provision of signed and dated informed consent form online
Male or female, aged 18 or older
Affected by PF as a member of at least one of the following cohorts:
An individual diagnosed with PF or ILD, including those who are post lung transplant, or
An individual who has cared (currently or in the past) for an individual with PF or ILD, and / or
A family member (defined as parent, full or half-sibling, or child) of an individual with PF or ILD.
Has internet access and a valid email address.

Exclusion Criteria

An individual who meets any of the following criteria will be excluded from participation in this study:
Primary residence or place of care is outside of the US.
Inability or unwillingness of a participant to provide informed consent or comply with study protocol.
Any condition or circumstance not listed above, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study.
Patients who were diagnosed with any of the below lung diseases. Similarly caregivers and family members associated with these diseases would be excluded.
Lymphangioleiomyomatosis (LAM)
Pulmonary alveolar proteinosis (PAP)
Cystic fibrosis (CF)
Amyloidosis

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT05382572) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pulmonary Fibrosis Treatment Options in Chicago, IL

If you're searching for pulmonary fibrosis treatment options in Chicago, IL, this clinical trial (NCT05382572) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pulmonary fibrosis clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Fibrosis Trials in Chicago, IL

See all pulmonary fibrosis clinical trials recruiting in Chicago — not just this study.

Browse Pulmonary Fibrosis Trials in Chicago →

Browse More Trials by Condition

Pulmonary Fibrosis TrialsFibromyalgia TrialsInterstitial Lung Disease TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL